Quick Answer
Bioquest Corp reported Operating Income Loss of -$817.9 thousand for the year ending 2022.
- Bioquest Corp showed an increase of +62.8% in Operating Income Loss from 2021 to 2022.
- This data is from Bioquest Corp's annual report (Form 10-K), filed with the SEC on August 15, 2022.
- XBRL data for this metric is available from 2013 to 2022 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: -$259.00 | Q4 2012: -$3.3 thousand | Q1 2013: -$2.4 thousand | Q3 2013: -$5.0 thousand | Q4 2013: -$3.3 thousand | Q1 2014: -$1.2 thousand | Q4 2014: -$890.0 thousand | Q1 2015: -$901.0 thousand | Q4 2019: -$11.7 thousand | Q1 2020: -$194.8 thousand | Q3 2020: -$321.6 thousand | Q4 2020: -$629.2 thousand | Q1 2021: -$564.6 thousand | Q3 2021: -$464.1 thousand | Q4 2021: -$176.6 thousand | Q1 2022: $52.7 thousand | Q3 2022: -$49.7 thousand.
- Over the full 5 years of available data (2013 to 2022), Bioquest Corp's Operating Income Loss has declined by 9,781.8%.
- Historical annual values: Fiscal year 2022: -$817.9 thousand | Fiscal year 2021: -$2.20 million | Fiscal year 2020: -$356.6 thousand | Fiscal year 2014: -$251.9 thousand | Fiscal year 2013: -$8.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: